Experimental Cancer Drug Use Increased By Trial "Hype" - FDA Cmte. Guest

The compassionate-use market for experimental cancer drugs has increased as a result of pharmaceutical industry promotions of early clinical results, Marti Nelson Cancer Research Foundation Director Robert Erwin told FDA's Oncologic Drugs Advisory Committee Dec. 14.